| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 30 |
| 1 | ACETAMINOPHEN | 21 |
| 2 | LENALIDOMIDE | 21 |
| 3 | ASPIRIN | 20 |
| 4 | ASPIRIN 325 MG | 20 |
| 5 | ASPIRIN 81 MG | 20 |
| 6 | GABAPENTIN | 18 |
| 7 | ATORVASTATIN CALCIUM | 17 |
| 8 | LEVOTHYROXINE SODIUM | 17 |
| 9 | METHOTREXATE SODIUM | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POLYETHYLENE GLYCOL-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM BICARBONATE | 1 | 0.0435 |
| 1 | ACORAMIDIS HYDROCHLORIDE | 1 | 0.0027 |
| 2 | METEX | 1 | 0.0026 |
| 3 | CICLOPIROX OLAMINE | 1 | 0.0021 |
| 4 | DESOGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | 1 | 0.0019 |
| 5 | VIMSELTINIB | 1 | 0.0018 |
| 6 | SAXAGLIPTIN | 2 | 0.0014 |
| 7 | CUPRIC CHLORIDE | 1 | 0.0013 |
| 8 | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | 1 | 0.0012 |
| 9 | 12%AZELAIC ACID | 1 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 42 |
| 1 | Corticosteroid [EPC] | 36 |
| 2 | Loop Diuretic [EPC] | 34 |
| 3 | Kinase Inhibitor [EPC] | 26 |
| 4 | Thalidomide Analog [EPC] | 26 |
| 5 | Proton Pump Inhibitor [EPC] | 22 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 21 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 20 |
| 8 | Insulin Analog [EPC] | 19 |
| 9 | Vitamin C [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Methylating Agent [EPC] | 1 | 0.0010 |
| 1 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 2 | 0.0008 |
| 2 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 3 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 4 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 5 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 3 | 0.0003 |
| 6 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 6 | 0.0003 |
| 7 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 8 | GLP-2 Analog [EPC] | 3 | 0.0002 |
| 9 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |